We have compared the performance of our in-house constructed delayed-extraction linear MALDI-TOF instrument with our newly acquired commercial PerSeptive STR MALDI-TOF instrument with respect to sensitivity and mass spectrum quality. In linear mode, our in-house constructed instrument appears to be approximately one order of magnitude more sensitive than the commercial instrument (I finale amounts of peptide give signals with signal-to-noise ratios in excess of 100: 1 in the in-house constructed device). The commercial instrument gives very high quality spectra for -10fmol amounts of peptide in the reflecting mode. We continue to implement improvements to the commercial instrumentation that we believe will ultimately lead to further enhancements in performance.
Showing the most recent 10 out of 67 publications